Shares of companies involved in psychedelic-related therapies are surging in premarket trading Monday after President Donald Trump signed an executive order to expedite research and access.
Psychedelic Stocks Soar as Trump Signs Order to Ease Access
Shares of companies involved in psychedelic-related therapies are surging in premarket trading Monday after President Donald Trump signed an executive order to expedite research and access.
This article was originally published by
Bloomberg Markets
and is republished here under license.
Leave a Reply